These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9084967)

  • 41. Treatment of gustatory sweating with low-dose botulinum toxin A: a case report.
    Bakke M; Max Thorsen N; Bardow A; Dalager T; Eckhart Thomsen C; Regeur L
    Acta Odontol Scand; 2006 Jun; 64(3):129-33. PubMed ID: 16809188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral glycopyrrolate for the treatment of Hailey-Hailey disease.
    Kaniszewska M; Rovner R; Arshanapalli A; Tung R
    JAMA Dermatol; 2015 Mar; 151(3):328-9. PubMed ID: 25651401
    [No Abstract]   [Full Text] [Related]  

  • 43. The Effect of Glycopyrrolate on Nocturnal Sialorrhea in Patients Using Clozapine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial.
    Man WH; Colen-de Koning JC; Schulte PF; Cahn W; van Haelst IM; Doodeman HJ; Egberts TC; Heerdink ER; Wilting I
    J Clin Psychopharmacol; 2017 Apr; 37(2):155-161. PubMed ID: 28129312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of topical glycopyrrolate in patients with facial hyperhidrosis: a randomized, multicentre, double-blinded, placebo-controlled, split-face study.
    Hyun MY; Son IP; Lee Y; Choi HG; Park KY; Li K; Kim BJ; Seo SJ; Kim MN; Hong CK
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):278-282. PubMed ID: 24909188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of glycopyrrolate and atropine in ameliorating the adverse effects of imidocarb dipropionate in horses.
    Donnellan CM; Page PC; Nurton JP; van den Berg JS; Guthrie AJ
    Equine Vet J; 2013 Sep; 45(5):625-9. PubMed ID: 23461655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.
    Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok R; Drew J; Quiring J; Pariser DM
    J Am Acad Dermatol; 2019 Jan; 80(1):128-138.e2. PubMed ID: 30003988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycopyrrolate for antidepressant-associated excessive sweating.
    Mago R
    J Clin Psychopharmacol; 2013 Apr; 33(2):279-80. PubMed ID: 23422382
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
    Mier RJ; Bachrach SJ; Lakin RC; Barker T; Childs J; Moran M
    Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1214-8. PubMed ID: 11115305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Glycopyrrolate treatment for drooling in an adult with cerebral palsy].
    Neverlien PO; Sørumshagen L; Eriksen T; Grinna T; Kvalshaugen H; Lind AB
    Tidsskr Nor Laegeforen; 2001 Jan; 121(2):187-8. PubMed ID: 11475197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improvement of diabetic autonomic gustatory sweating by botulinum toxin type A.
    Restivo DA; Lanza S; Patti F; Giuffrida S; Marchese-Ragona R; Bramanti P; Palmeri A
    Neurology; 2002 Dec; 59(12):1971-3. PubMed ID: 12499494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clonidine in the management of asymmetrical gustatory facial sweating: an N-of-1 trial.
    Nesathurai S; Harvey DT
    Arch Phys Med Rehabil; 1996 Sep; 77(9):906-8. PubMed ID: 8822684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.
    Garnock-Jones KP
    Paediatr Drugs; 2012 Aug; 14(4):263-9. PubMed ID: 22646067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The beneficial effect of topical glycopyrrolate in a patient with neuropathic lower extremity pain.
    Schwartz L; Quezado Z
    Pain Med; 2012 Mar; 13(3):484-5. PubMed ID: 22295952
    [No Abstract]   [Full Text] [Related]  

  • 54. Intramuscular neostigmine and glycopyrrolate safely accelerated bowel evacuation in patients with spinal cord injury and defecatory disorders.
    Rosman AS; Chaparala G; Monga A; Spungen AM; Bauman WA; Korsten MA
    Dig Dis Sci; 2008 Oct; 53(10):2710-3. PubMed ID: 18338263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Eccrine nevus affecting the forearm of an 11-year-old girl successfully controlled with topical glycopyrrolate.
    Dua J; Grabczynska S
    Pediatr Dermatol; 2014; 31(5):611-2. PubMed ID: 23534977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The 2017 Banting Memorial Lecture The diabetic lower limb - a forty year journey: from clinical observation to clinical science.
    Boulton AJM
    Diabet Med; 2019 Dec; 36(12):1539-1549. PubMed ID: 30659650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A medical alternative for the treatment of localized hyperhidrosis].
    Cladellas Gutiérrez E; Callejas Pérez MA; Grimalt Santacana R
    Arch Bronconeumol; 2008 Dec; 44(12):692-3. PubMed ID: 19091240
    [No Abstract]   [Full Text] [Related]  

  • 58. Gustatory sweating in people with type 1 and type 2 diabetes mellitus: Prevalence and risk factors.
    Klarskov CK; von Rohden E; Thorsteinsson B; Tarnow L; Lommer Kristensen P
    Endocrinol Diabetes Metab; 2021 Oct; 4(4):e00290. PubMed ID: 34505414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gustatory sweating in a diabetic end-stage renal disease patient maintained on hemodialysis.
    Ejaz AA; Zabaneh RI; Popli SS; Ing TS; Leehey DJ
    Nephron; 1995; 69(3):337. PubMed ID: 7753271
    [No Abstract]   [Full Text] [Related]  

  • 60. Oral glycopyrrolate for refractory pediatric and adolescent hyperhidrosis.
    Kumar MG; Foreman RS; Berk DR; Bayliss SJ
    Pediatr Dermatol; 2014; 31(1):e28-30. PubMed ID: 24266878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.